Overview
Yuzo Inaba practices practicing medicine in Fuji, Japan.
Their clinical expertise encompasses Gumma, Upper Tract Urothelial Carcinoma (UTUC), Bone Tumor, Prostate Cancer, and Nephrectomy.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yuzo Inaba
Is Yuzo Inaba a top-rated expert for Gumma?
MediFind is an objective health platform that identifies experts based on real-world data. Yuzo Inaba is classified as an Experienced expert for Gumma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yuzo Inaba participate in research or clinical trials?
Yes. Yuzo Inaba has published 8 articles and abstracts on conditions like Gumma. You can view a list of Yuzo Inaba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorInaba isExperienced. Learn about Bone Tumor.
- GummaInaba isExperienced. Learn about Gumma.
- NephrectomyInaba isExperienced. Learn about Nephrectomy.
- Prostate CancerInaba isExperienced. Learn about Prostate Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)
- Urothelial CancerInaba isExperienced. Learn about Urothelial Cancer.